INPERSOL LC WITH DEXTROSE 1.5% LIQ DIN 01965034
Health Canada record
| Active ingredient(s) | CALCIUM CHLORIDE .184 MG; MAGNESIUM CHLORIDE .051 MG; DEXTROSE 15 MG; SODIUM LACTATE 4.48 MG; SODIUM CHLORIDE 5.38 MG |
|---|---|
| Dosage form | Liquid |
| Route | Haemodialysis |
| Schedule | ETHICAL |
| Class | Human |
| ATC | B05ZA HEMODIALYTICS, CONCENTRATES |
| Original market date | 31-Dec-1993 |
| Current status date | 31-Jul-2007 |
| Source | Health Canada DPD |
Establishment licence of the holder
Abbott Laboratories Co. — licence 3-002635, currently licensed, last inspection rating C (2024-09-23).
No Canadian shortage report is currently matched to this DIN.
Request a quote for INPERSOL LC WITH DEXTROSE 1.5% LIQ